MarkFesenMDFACP

PubMed

• 63 citations
  Randomized Comparison of Epoetin Alfa (40,000 U Weekly) and Darbepoetin Alfa (200 μg Every 2 Weeks) in Anemic Patients with Cancer Receiving Chemotherapy
  Roger J. Waltzman, Christopher Croot, Glen R. Justice, Mark R. Fesen, Veena Charu
  The Oncologist. 2005-09-01
• 19 citations
  Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
  John K. Buolamwini, Krishnamchari Raghavan, Mark R. Fesen, Yves Pommier, Kurt W. Kohn
  Pharmaceutical Research. 1996-12-01
• 115 citations
  (−)-Arctigenin as a Lead Structure for Inhibitors of Human Immunodeficiency Virus Type-1 Integrase
  Eckart Eich, Heinz H. Pertz, Macki Kaloga, Jutta Schulz, M. R. Fesen
  Journal of Medicinal Chemistry. 1996-01-05

Journal Articles

• Waltzman, R., Croot, C., Justice, GR., Fesen, MR., Charu, V., Williams, D., Oncologist, 1/1/2005
• Deitcher, SR., Fesen, MR., Kiproff, PM., Hill, PA., Li, X., Semba, CP., Journal of Clinical Oncology, 1/1/2002
• Buolamwini, JK., Raghavan, K., Fesen, MR., Pommier, Y., Kohn, KW., Weinstein, JN., Pharmeceutical Research, 1/1/1996
• Eich, E., Pertz, H., Kaloga, M., Schulz, J., Fesen, M., Mazumder, A., and Pommier, Y., Journal of Medicinal Chemistry, 1/1/1996
• Raghavan, K., Buolamwini, J., Fesen, M., Pommier, Y., Kohn, K., Weinstein, J., Journal of Medicinal Chemistry, 1/1/1995
• Burke, TR Jr., Fesen, M., Mazumder, A., Wang, J., Carothers, A., Grunberger, D., Driscoll, J., Kohn, K., Pommier, Y, Journal of Medicinal Chemistry, 1/1/1995
• Fesen MR, Oncology, 1/1/1995
• Fesen, M., Pommier, Y., Leteurtre, F., Hiroguchi, S., Yung, J., and Pommier, Y., Biochemical Pharmacology, 1/3/1994
• Leteurtre, F., Kohlhagen, G., Fesen, M., Tanizawa, A., Kohn, K., and Pommier, Y., Journal of Biological Chemistry, 1/1/1994
• Mazumber, R., Engleman, A., Craigie, R., Fesen, M., Pommier, Y., Nucleic Acids Research, 1/1/1994
• Eich, E., Pertz, M., Kaloga, M., Schulz, J., Fesen, MR., Mazumder, A., Pommier, Y., European Journal of Pharmaceutical Sciences, 1/1/1994
• Letuertre, F., Fesen, M., Kohlhagen, G., Kohn, K., and Pommier, Y, Biochemistry, 1/31/1993
• Pommier, Y., Leteurtre, F., Fesen, M., Fujimori, A., Bertrand, R., Solary, E., and Kohn, K., Cancer Investigations, 1/9/1993
• Rice, W., Schaeffer, C., Graham, L., Bu, M., McDougal, S., Orloff, S., Villinger, F., Young, M., Oroszlan, S., Fesen, M., Pommier, Y., Mendeleyev, J., Kun, E., Proceedings of the National Academy of Science (USA), 1/1/1993
• Fesen, M., Kurt Kohn, Francois Leteurtre, and Yves Pommier, Proceedings of the National Academy of Science (USA), 1/1/1993
• Fesen, M., and Pommier, Y., Journal of Biological Chemistry, 1/1/1989
• Fesen, M., and Harder, H., Chemicobiological Interactions, 1/1/1989
• Yamanshi, W., Fesen, M., Anderson, D., Valentine, J., Sy, A., Crandell, C., and Lester, P., Physiological Chemistry and Physics and Medical NMR, 1/1/1984
• Join now to see all

Books/Book Chapters

•  
  Fesen MRAMACOM American Management Association, New York, NY2009
•  
  Chapter: Topoisomerase II inhibitors 
  Pommier, Y., Fesen, M., and Goldwasser, F.Editors: Chabner, B. and Long, D..Lippincott-Raven Publishers1996

Abstracts/Posters

• Tra, F., Fesen, MR., Pianalto, M., Nisly., R., Journal of Clinical Oncology; ASCO Annual Meeting Proceedings, 1/1/2008
• Waltzman, RJ., Fesen, MR., Justice, GR., Croot, C., Williams, D., Journal of Clinical Oncology; ASCO Annual Meeting Proceedings, 1/1/2004
• Blayney, DW., Spiridonidis, H., Fesen, MR., McGuire, WP., Bhatia, AW., Hellman, RM., Terry, D., Tomita, D., American Society of Clinical Oncology, 1/1/2003

Lectures

•  
  New York University, New York, NY - 1/1/1994
•  
  Orlando, FL - 1/1/1993
•  
  New Orleans, LA - 1/1/1988